{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(5)"],"submitter":["Zhu FC"],"pubmed_abstract":["<h4>Background</h4>Hand, foot, and mouth disease (HFMD) has been emerging as an important public problem over the past few decades, especially in Asian and Pacific regions. A national program on EV71 vaccine development against HFMD was initiated in China, in 2008, which called for a need for seroepidemiological study for the target population.<h4>Methodology/principal findings</h4>This was a retrospective study conducted in Jiangsu Province, in October, 2010. We measured the neutralizing antibodies against EV71 and CoxA16 in a cohort of infants aged of 2, 7, 12, and 27-38 months and their mothers just before delivery. Series sera samples from 975 infants and 555 mothers were collected and analyzed. Questionnaires on the history of HFMD were completed in the survey. A total of 143 HFMD cas"],"journal":["PloS one"],"pagination":["e37206"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3360679"],"repository":["biostudies-literature"],"pubmed_title":["Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants."],"pmcid":["PMC3360679"],"pubmed_authors":["Xu K","Zhang WW","Mao QY","Ji H","Zeng Y","Wang H","Yao X","Deng F","Wang JZ","Li L","Li JX","Zhang YJ","Meng FY","Zhu FC","Song XF","Chu K","Dai WM","Liang ZL","Pan HX"],"additional_accession":[]},"is_claimable":false,"name":"Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.","description":"<h4>Background</h4>Hand, foot, and mouth disease (HFMD) has been emerging as an important public problem over the past few decades, especially in Asian and Pacific regions. A national program on EV71 vaccine development against HFMD was initiated in China, in 2008, which called for a need for seroepidemiological study for the target population.<h4>Methodology/principal findings</h4>This was a retrospective study conducted in Jiangsu Province, in October, 2010. We measured the neutralizing antibodies against EV71 and CoxA16 in a cohort of infants aged of 2, 7, 12, and 27-38 months and their mothers just before delivery. Series sera samples from 975 infants and 555 mothers were collected and analyzed. Questionnaires on the history of HFMD were completed in the survey. A total of 143 HFMD cas","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012","modification":"2025-04-04T08:48:32.096Z","creation":"2019-03-26T23:18:41Z"},"accession":"S-EPMC3360679","cross_references":{"pubmed":["22662137"],"doi":["10.1371/journal.pone.0037206"]}}